mall health and u.s. healthcare - qtrly results showed double-digit global revenue growth for all industries including brightree brands on a reported basis.
increased its fiscal 2020 capital expenditures guidance.
will be providing financial update during our quarterly conference call.
compname announces second-quarter 2021 results.
q4 sales rose 29 percent to $2.1 billion.
qtrly average daily use of patient management platform in a quarter increased 2 percent compared to last year.
sees q4 of 2021 to close its contract to cover 1 billion nights of patients with health care costs.
for q3 2021 expect to have approximately $2 billion in savings from continuing operations.
cobit sees results in q2 of fiscal 2021, including anticipated increase in revenue and earnings.
raises its fiscal 2021 earnings guidance.
compname announces second-quarter 2021 results.
compname reports fda clearance for resmed airmini, our world leading travel friendly, sleep app technology.
p&r will talk about that a little later in quarter.
compname reports second-quarter non-gaap earnings per share $0.73 excluding items.
compname says continues to balance revenue growth and gross margin improvements as well as ensuring that appropriate investment in both research and development in both r&d and gosai.
compname reports full-year 2021 results.
